TozinameranSecondary haemolytic uraemic syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1914卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19015-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：429 / 429

相关论文

共 50 条

[1] GemcitabineAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2022, 1887 (1) : 336 - 336
[2] CarfilzomibAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2024, 2036 (1) : 115 - 115
[3] TacrolimusAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2019, 1770 (1) : 359 - 359
[4] TacrolimusAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2023, 1955 (1) : 348 - 348
[5] RituximabAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2023, 1956 (1) : 451 - 451
[6] DeferasiroxAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2024, 2039 (1) : 174 - 174
[7] GemcitabineAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2023, 1956 (1) : 245 - 245
[8] CarfilzomibAtypical haemolytic uraemic syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 107 - 107
[9] CiprofloxacinFirst report of haemolytic uraemic syndrome: case report
Reactions Weekly, 2002, 911 (1) : 7 - 7
[10] ClopidogrelFirst report of haemolytic uraemic syndrome: case report
Reactions Weekly, 2000, 806 (1) : 7 - 7

← 1 2 3 4 5 →